Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.
about
Prophylactic oophorectomy in premenopausal women and long-term healthSex and Gender Differences in Central Nervous System-Related DisordersSex differences in Parkinson's diseaseEstrogen ameliorates microglial activation by inhibiting the Kir2.1 inward-rectifier K(+) channel.Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007The complexities of hormonal influences and risk of Parkinson's diseaseRisk of Parkinson's disease after tamoxifen treatment.Female reproductive factors, menopausal hormone use, and Parkinson's disease.Brain renin-angiotensin system and dopaminergic cell vulnerabilityParkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.Estrogen-related and other disease diagnoses preceding Parkinson's diseaseFormulations of hormone therapy and risk of Parkinson's disease.Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studiesMPTP Neurotoxicity and Testosterone Induce Dendritic Remodeling of Striatal Medium Spiny Neurons in the C57Bl/6 MouseAging, Angiotensin system and dopaminergic degeneration in the substantia nigra.Hormone replacement therapy and risk for neurodegenerative diseases.Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.Male/Female differences in neuroprotection and neuromodulation of brain dopamineCaffeine intake, smoking, and risk of Parkinson disease in men and women.Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's diseaseGenetics of iron regulation and the possible role of iron in Parkinson's disease.Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.Alzheimer's disease and other neurological disorders.Reproductive factors, exogenous estrogen use, and risk of Parkinson's diseasePrevalence of narcolepsy in King County, Washington, USA.Evidence for gender differences in cognition, emotion and quality of life in Parkinson's disease?Movement disorders in women: a review.Reproductive factors and Parkinson's disease risk in Danish women.Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.The relevance of gender in Parkinson's disease: a review.Increase of Reproductive Life Span Delays Age of Onset of Parkinson's Disease.Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.Peripheral Lymphocyte Subsets as a Marker of Parkinson's Disease in a Chinese Population.Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.Sex-related differences in oxidative stress and neurodegeneration.Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.Gender differences in Parkinson's disease
P2860
Q24655584-74748E41-8FD5-4590-B3B4-AF18F0C557E9Q26744569-7D1DFCE6-5D54-423E-B3C4-88024F0A19F8Q27025107-141143A7-ADEE-446D-A45E-99522A14A234Q27333476-41A8CB97-3DF6-4591-BFE4-B847187F7D8BQ28387116-E4CCAB0C-45C8-4F78-8CFB-8CF9DFB2CB03Q28389039-C2C4F04A-51D8-419F-9729-21C132930C9EQ33552831-B2EDF94E-D38E-4B6C-B024-3A8896BC9023Q33756791-FC29AC73-340A-4A4A-B9DE-7A240AEAC5A7Q33861951-445BB9AD-5A33-4258-B308-3B7A2405A122Q33874635-84D931E0-BC73-433E-89D7-EE826C4045EFQ34144121-B2445004-9E55-473F-A142-B0738083E2F1Q34437648-D3E8FE9D-A912-4D94-B408-A9B03DF644C7Q35049313-687CC0F8-B954-403E-927E-479CECE3A279Q35101285-6A2A5831-C1D7-40E1-849A-16E38437538FQ35806742-38AAA9EE-A357-4AE5-90A3-7868FF831645Q35884815-E6D6EFFC-DBD8-4153-8D8B-B49C8769AD8EQ35971342-CBC2E42D-B0BC-4E2F-87B5-F9114612AEFAQ35972056-9FBE8280-3B29-4BBD-A8BF-21DAE0041891Q36019163-F9441CB8-3D6F-43AE-8ED3-D5F031EB69ECQ36576487-FC49C8FF-B303-4E4C-BBEF-9FA6EB4950B7Q36815145-A05C5228-2C0F-4E99-ABDE-856196CB0CA8Q36854132-70C46373-FA0F-41E4-A0EE-2799B00B879DQ36946824-016708F4-B623-4ACF-85CE-A6F583946744Q37362137-D50ADB5F-702E-43DB-9EE6-E810C7B23B6CQ37368887-9F5F398D-32A9-434D-80F7-4ECDD8B23151Q37514014-C6769324-D3A7-4AAB-A70B-A5C625A09385Q38154864-C6753C96-30E6-4ED7-9CE2-36261EE4EA38Q38205929-C2C07EB8-84E6-4C99-A529-0AFDFF648D34Q38260925-9759CF98-E8B1-4991-A2E2-6A057232DE23Q39039214-5ED3AA4B-338B-4FFE-A992-8BE4DBAB9771Q46027706-72BCC7B8-6A60-499D-8C4C-225EBF1EFA77Q47623516-7FCC5889-80FC-4353-8704-7B22391125F0Q47672476-53BF59DA-3F32-4802-B3C5-58C956A7F214Q48439931-2D90855C-9431-4E1D-B210-95E82BE2695AQ49601287-2AF4AB95-B038-4CA7-B2DE-2357BC6CB472Q49817768-69930E16-9C71-4DCE-B186-D3C43AD4D071Q57779630-9D764726-138F-4D5C-8A63-A4396E48C8E2
P2860
Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Effect of reproductive factors ...... the risk of Parkinson disease.
@en
Effect of reproductive factors ...... the risk of Parkinson disease.
@nl
type
label
Effect of reproductive factors ...... the risk of Parkinson disease.
@en
Effect of reproductive factors ...... the risk of Parkinson disease.
@nl
prefLabel
Effect of reproductive factors ...... the risk of Parkinson disease.
@en
Effect of reproductive factors ...... the risk of Parkinson disease.
@nl
P2093
P1433
P1476
Effect of reproductive factors ...... the risk of Parkinson disease.
@en
P2093
Bernstein AL
Leimpeter A
Van Den Eeden SK
P304
P356
10.1212/01.WNL.0000171344.87802.94
P407
P577
2005-08-01T00:00:00Z